The Trump administration's latest tariffs impacting medicine costs and pharma tariffs that may spare richest drugmakers dominate health news, alongside medical groups' warnings against visa fees for foreign doctors and Trump's potential move to force drugmakers to match European prices, while funding for credible autism research also sees significant investment despite previous controversies.

• How Trump’s Latest Tariffs May Affect Your Medicines — The New York Times Science -
• Trump’s Pharma Tariffs Spare Richest Drugmakers — The New York Times Science -
• Despite False Claims, Trump Funnels Millions Into Credible Autism Research — The New York Times Science -

• Medical Groups Warn Against Visa Fees for Foreign Doctors — The New York Times Science -
• Trump May Try to Force Drugmakers to Match European Prices — The New York Times Science -

Discussions around Kennedy's statement rejecting global health goals due to policy disagreements and the passing of harm-reduction leader Louise Vincent highlight critical issues and advocacy efforts within public health.

• Kennedy Says U.S. Rejects Global Health Goals — The New York Times Science -
• Louise Vincent, 49, Drug User Who Led Harm-Reduction Movement, Dies — The New York Times Science -

Artemis II astronauts' message of inclusivity sets a unifying tone for future space endeavors as they prepare for their mission.

• NASA Artemis II Astronauts Aim to Make Space Great for All — The New York Times Science -

Recent scientific news features the discovery of a Megaraptor fossil shedding light on a poorly understood dinosaur order, alongside a profile of science writer Franz Lidz who excels at demystifying complex archaeological subjects.

• The Megaraptor Had Giant Claws and an Appetite for Crocodilians — The New York Times Science -
• A Writer Who Delights in Demystifying the Arcane and Obscure — The New York Times Science -